A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting

NCT03021018 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Brivaracetam
DRUG: Lorazepam

Sponsor

UCB Biopharma S.P.R.L.